ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 160 filers reported holding ANTARES PHARMA INC in Q2 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,052,000 | +14.9% | 1,720,000 | 0.0% | 1.39% | +59.9% |
| Q4 2021 | $6,140,000 | -11.2% | 1,720,000 | -9.5% | 0.87% | +1.3% |
| Q3 2021 | $6,916,000 | -16.5% | 1,900,000 | 0.0% | 0.86% | -24.6% |
| Q2 2021 | $8,284,000 | +6.1% | 1,900,000 | 0.0% | 1.14% | -2.3% |
| Q1 2021 | $7,809,000 | +3.0% | 1,900,000 | 0.0% | 1.17% | +23.1% |
| Q4 2020 | $7,581,000 | +65.2% | 1,900,000 | +11.8% | 0.95% | +57.0% |
| Q3 2020 | $4,589,000 | -1.8% | 1,699,566 | 0.0% | 0.60% | +2.0% |
| Q2 2020 | $4,674,000 | +61.4% | 1,699,566 | +38.5% | 0.59% | -31.0% |
| Q1 2020 | $2,896,000 | -10.5% | 1,227,114 | +78.3% | 0.86% | +41.7% |
| Q4 2019 | $3,235,000 | +235.6% | 688,237 | +138.8% | 0.61% | +156.1% |
| Q3 2019 | $964,000 | – | 288,237 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |